You have 9 free searches left this month | to do more
Showing 1 - 25 of
3,251 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
BMS-986253 in Myelodysplastic Syndromes
Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-13
Jan 13, 2022
T
Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes
No longer available
  • Myelodysplastic Syndromes
  • (no location specified)
2021-09-08
Sep 8, 2021
C
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes - 2009
Completed
  • Leukemias
  • Myelodysplastic Syndromes
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
2021-12-07
Dec 7, 2021
M
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Active, not recruiting
  • Myelodysplastic Syndromes
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-05-07
May 7, 2021
M
Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS) - 2021
Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
2021-09-15
Sep 15, 2021
U
A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
Active, not recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Rochester, New York
    University of Rochester
2022-01-04
Jan 4, 2022
A
ACE-536 Extension Study - Myelodysplastic Syndromes - 2020
Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
    Acceleron Investigative Site
2021-04-29
Apr 29, 2021
A
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
2021-10-01
Oct 1, 2021
T
A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes
Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
2021-09-23
Sep 23, 2021
W
CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy - 2018
Terminated
  • Previously Treated Myelodysplastic Syndromes
  • 6,8-bis(benzylthio)octanoic acid
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2021-07-01
Jul 1, 2021
C
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid - 2021
Completed
  • Myelodysplastic Syndromes
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2021-08-04
Aug 4, 2021
G
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Withdrawn
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
2021-07-05
Jul 5, 2021
W
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-06-15
Jun 15, 2021
U
Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes
Recruiting
  • Myelodysplastic Syndromes
    • Toulouse, France
      IUCT-Oncopole University Hospital
    2021-03-16
    Mar 16, 2021
    M
    Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
    Not yet recruiting
    • Acute Myeloid Leukemia Myelodysplastic Syndromes
    • Gliwice, Poland
      Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytu
    2021-05-03
    May 3, 2021
    S
    Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    2021-11-29
    Nov 29, 2021
    S
    LBH589 in Refractory Myelodysplastic Syndromes (MDS) - 2011
    Terminated
    Has Results
    • Myelodysplastic Syndromes (MDS)
    • Fort Myers, Florida
    • +6 more
    2021-11-18
    Nov 18, 2021
    M
    Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes - 2021
    Completed
    • Myelodysplastic Syndromes
    • selinexor (KPT-330)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-04-07
    Apr 7, 2021
    U
    Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes
    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • somatic cytogenetic and genetic characterization
    • Brest, France
    • +2 more
    2021-01-06
    Jan 6, 2021
    A
    A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes - 2020
    Completed
    • Myelodysplastic Syndrome (MDS)
    • AMV564 14-Day CIV
    • Duarte, California
    • +4 more
    2021-10-11
    Oct 11, 2021
    U
    Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
    Recruiting
    • High Grade Myelodysplastic Syndromes
    • Aurora, Colorado
      Universtiy of Colorado Denver
    2021-10-19
    Oct 19, 2021
    U
    Biocollection in MyeloDysplastic Syndrome (P-MDS)
    Not yet recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • description of MDS pzatient cohort
    • (no location specified)
    2021-04-30
    Apr 30, 2021
    M
    Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
    Recruiting
    • Refractory Chronic Myelomonocytic Leukemia
    • Refractory Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    2021-08-31
    Aug 31, 2021
    A
    Study of ACE-536 for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) - 2018
    Completed
    • Anemia
    • Dresden, Germany
      Acceleron Investigative Site
    2021-04-29
    Apr 29, 2021
    T
    Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly
    Recruiting
    • Myelodysplastic Syndromes
    • Observational
    • Dresden, Germany
    • +1 more
    2021-08-10
    Aug 10, 2021